Belpointe Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-6,051
| Closed | -$219K | – | 724 |
|
|
2023
Q3 | $219K | Sell |
6,051
-2,011
| -25% | -$72.9K | 0.02% | 573 |
|
|
2023
Q2 | $287K | Sell |
8,062
-8,809
| -52% | -$314K | 0.03% | 463 |
|
|
2023
Q1 | $600K | Sell |
16,871
-14,426
| -46% | -$513K | 0.03% | 489 |
|
|
2022
Q4 | $1.1M | Sell |
31,297
-927
| -3% | -$32.6K | 0.07% | 296 |
|
|
2022
Q3 | $949K | Buy |
32,224
+13,972
| +77% | +$411K | 0.06% | 308 |
|
|
2022
Q2 | $994K | Buy |
18,252
+1,227
| +7% | +$66.8K | 0.07% | 297 |
|
|
2022
Q1 | $928K | Buy |
17,025
+2,211
| +15% | +$121K | 0.06% | 359 |
|
|
2021
Q4 | $817K | Sell |
14,814
-140
| -0.9% | -$7.72K | 0.05% | 378 |
|
|
2021
Q3 | $713K | Buy |
14,954
+3,622
| +32% | +$173K | 0.05% | 403 |
|
|
2021
Q2 | $564K | Buy |
11,332
+894
| +9% | +$44.5K | 0.04% | 462 |
|
|
2021
Q1 | $466K | Buy |
10,438
+12
| +0.1% | +$536 | 0.04% | 460 |
|
|
2020
Q4 | $480K | Sell |
10,426
-149
| -1% | -$6.86K | 0.04% | 416 |
|
|
2020
Q3 | $498K | Sell |
10,575
-1,119
| -10% | -$52.7K | 0.06% | 333 |
|
|
2020
Q2 | $597K | Buy |
11,694
+52
| +0.4% | +$2.66K | 0.08% | 263 |
|
|
2020
Q1 | $552K | Sell |
11,642
-425
| -4% | -$20.2K | 0.1% | 234 |
|
|
2019
Q4 | $708K | Buy |
12,067
+6,711
| +125% | +$394K | 0.09% | 239 |
|
|
2019
Q3 | $286K | Sell |
5,356
-58
| -1% | -$3.1K | 0.05% | 398 |
|
|
2019
Q2 | $271K | Sell |
5,414
-2,436
| -31% | -$122K | 0.05% | 347 |
|
|
2019
Q1 | $410K | Buy |
7,850
+2,824
| +56% | +$147K | 0.08% | 197 |
|
|
2018
Q4 | $240K | Buy |
5,026
+541
| +12% | +$25.8K | 0.06% | 311 |
|
|
2018
Q3 | $225K | Buy |
+4,485
| New | +$225K | 0.04% | 426 |
|
|
2017
Q4 | – | Sell |
-4,027
| Closed | -$204K | – | 476 |
|
|
2017
Q3 | $204K | Buy |
+4,027
| New | +$204K | 0.05% | 392 |
|